FundPlus

FundPlus operates as an open-ended investment vehicle dedicated to long-term equity financing in the innovative Life Sciences sector, with a strategic concentration on Belgian enterprises. The fund aims to build lasting shareholder value while simultaneously strengthening Belgium's competitive position within the global biotechnology and healthcare landscape. With a patient capital approach, FundPlus supports companies through multiple growth stages, allowing for the extended development timelines typically required in life sciences innovation.

The investment strategy of FundPlus centers on identifying promising therapeutic, diagnostic, and medical technology companies with breakthrough potential. Their portfolio typically includes early to mid-stage companies developing novel treatments for unmet medical needs, advanced diagnostic platforms, and cutting-edge healthcare technologies. By providing not just financial resources but also strategic guidance and industry connections, FundPlus helps accelerate the growth trajectory of its portfolio companies in the competitive life sciences market.

Beyond pure financial returns, FundPlus distinguishes itself through its commitment to generating meaningful societal impact. The fund evaluates potential investments based on their capacity to address significant healthcare challenges, improve patient outcomes, and enhance quality of life. This dual-objective approach of financial sustainability and positive social contribution reflects the fund's recognition that the most valuable life sciences innovations are those that deliver both economic and humanitarian benefits.

As a key player in Belgium's thriving life sciences ecosystem, FundPlus contributes to the country's emergence as a European biotech hub. The fund leverages Belgium's strong academic research institutions, established pharmaceutical presence, and supportive regulatory environment to identify promising investment opportunities. Through its focused investment approach, FundPlus aims to create a virtuous cycle where successful portfolio companies reinforce Belgium's reputation for life sciences excellence, attracting additional talent and capital to the region and fostering sustainable industry growth for decades to come.